Skip to main content

Table 1 Clinical data and 18F-FDG PET/CT findings for 28 patients with PM/DM

From: 18F-FDG PET/CT in patients with polymyositis/dermatomyositis: correlation with serum muscle enzymes

Patient No.

Age (years)/sex

PM/DM

CK (U/l)

Aldolase (U/l)

Number of positive regions

Positive uptake in muscles*

Total score

Mean SUVmean**

Mean SUVmax***

U

S

M

C

UT

LT

L

B

T

1

52/F

DM

27

8.5

1

        

â–¡

2

0.80

1.26

2

68/F

DM

392

5.2

12

 

â–¡

â–¡

â–¡

 

â–¡

â–¡

â–¡

 

16

1.29

1.88

3

55/F

DM

83

10.6

1

 

â–¡

       

2

0.85

1.33

4

58/F

DM

443

7.8

6

â–¡

â–¡

 

â–¡

     

6

1.17

1.69

5

59/F

DM

45

4.6

0

         

0

0.79

0.94

6

77/F

DM

174

20.1

0

         

0

0.79

0.91

7

71/M

DM

270

27.6

18

â–¡

â–¡

â–¡

â–¡

â–¡

â–¡

â–¡

â–¡

â–¡

29

1.92

2.70

8

44/F

DM

79

8.1

15

â–¡

â–¡

â–¡

 

â–¡

â–¡

â–¡

â–¡

â–¡

29

1.48

2.17

9

68/F

PM

1692

15.8

13

â–¡

â–¡

â–¡

â–¡

 

â–¡

 

â–¡

â–¡

13

1.39

1.78

10

56/F

DM

3284

31.6

17

â–¡

â–¡

â–¡

â–¡

â–¡

â–¡

â–¡

â–¡

â–¡

23

1.41

1.82

11

46/M

DM

2583

18.1

12

â–¡

â–¡

â–¡

â–¡

   

â–¡

â–¡

20

1.87

2.83

12

53/F

DM

3329

38.0

12

â–¡

â–¡

â–¡

  

â–¡

 

â–¡

â–¡

20

1.93

2.68

13

69/F

PM

3946

59.5

14

â–¡

â–¡

â–¡

â–¡

â–¡

  

â–¡

â–¡

22

1.58

1.92

14

67/F

PM

362

9.8

0

         

0

1.01

1.24

15

68/F

PM

2811

33.2

4

       

â–¡

â–¡

4

1.19

1.44

16

70/F

PM

1481

18.8

6

 

â–¡

     

â–¡

â–¡

6

1.03

1.31

17

58/M

PM

75

6.3

0

         

0

0.75

0.90

18

65/F

DM

1302

25.2

2

       

â–¡

â–¡

2

0.95

1.15

19

47/F

DM

660

19.4

18

â–¡

â–¡

â–¡

â–¡

â–¡

â–¡

â–¡

â–¡

â–¡

35

1.46

2.03

20

64/M

PM

2029

42.6

18

â–¡

â–¡

â–¡

â–¡

â–¡

â–¡

â–¡

â–¡

â–¡

29

1.83

2.29

21

70/F

PM

236

5.8

18

â–¡

â–¡

â–¡

â–¡

â–¡

â–¡

â–¡

â–¡

â–¡

21

1.51

2.16

22

70/F

PM

215

9.1

16

â–¡

â–¡

â–¡

â–¡

â–¡

â–¡

 

â–¡

â–¡

26

1.40

1.84

23

43/F

DM

37

8.2

0

         

0

0.74

0.90

24

42/M

DM

92

8.1

15

â–¡

â–¡

â–¡

â–¡

â–¡

â–¡

 

â–¡

â–¡

21

1.33

1.80

25

63/F

DM

3207

53.1

18

â–¡

â–¡

â–¡

â–¡

â–¡

â–¡

â–¡

â–¡

â–¡

36

2.00

2.70

26

59/M

DM

354

11.1

18

â–¡

â–¡

â–¡

â–¡

â–¡

â–¡

â–¡

â–¡

â–¡

32

1.68

2.35

27

58/F

PM

601

24.0

18

â–¡

â–¡

â–¡

â–¡

â–¡

â–¡

â–¡

â–¡

â–¡

34

2.03

2.90

28

60/F

DM

210

18.4

18

â–¡

â–¡

â–¡

â–¡

â–¡

â–¡

â–¡

â–¡

â–¡

24

1.51

1.91

  1. *The regions of positive 18F-FDG at least in either side of the region are indicated by open squares
  2. **Average SUVmean obtained for the 18 muscle regions
  3. ***Average SUVmax obtained for the 18 muscle regions
  4. PM/DM polymyositis/dermatomyositis, CK creatine kinase, SUVmean mean standardized uptake value, SUVmax maximum standardized uptake value, U upper arms, S shoulders, M sternocleido-mastoid muscles, C paraspinal muscles of cervical level, UT paraspinal muscles of upper thoracic level, LT paraspinal muscles of lower thoracic level, L paraspinal muscles of lumbar level, B buttocks, T upper part of the thighs